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Background: The epidemiologic study of comorbidities of an index health problem represents a methodological
challenge. This study cross-sectionally describes and analyzes the comorbidities associated with dementia in older
patients and reviews the existing similarities and differences between identified comorbid diseases using the
statistical methods most frequently applied in current research.
Methods: Cross-sectional study of 72,815 patients over 64 seen in 19 Spanish primary care centers during 2008.
Chronic diseases were extracted from electronic health records and grouped into Expanded Diagnostic Clusters®.
Three different statistical methods were applied (i.e., analysis of prevalence data, multiple regression and factor
analysis), stratifying by sex.
Results: The two most frequent comorbidities both for men and women with dementia were hypertension and
diabetes. Yet, logistic regression and factor analysis demonstrated that the comorbidities significantly associated
with dementia were Parkinson’s disease, congestive heart failure, cerebrovascular disease, anemia, cardiac arrhythmia,
chronic skin ulcers, osteoporosis, thyroid disease, retinal disorders, prostatic hypertrophy, insomnia and anxiety
and neurosis.
Conclusions: The analysis of the comorbidities associated with an index disease (e.g., dementia) must not be
exclusively based on prevalence rates, but rather on methodologies that allow the discovery of non-random
associations between diseases. A deep and reliable knowledge about how different diseases are grouped and
associated around an index disease such as dementia may orient future longitudinal studies aimed at unraveling
causal associations.
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Dementia is characterized by the impairment of memory
and learning and at least one other cognitive domain
(i.e., aphasia, apraxia, agnosia or executive function),
representing a highly severe functional deterioration
that interferes with the patient’s daily functional abil-
ities and independence [1]. Dementia is not simply a
disease; it is a syndrome caused by different etiologies
and it has a substantial medical and social impact. Al-
though recent door-to-door studies suggest a decreasing* Correspondence: acalderon.iacs@aragon.es
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distribution, and reproduction in any mediumincidence of dementia [2,3], its crude prevalence has in-
creased continuously over the past decades due to aging
populations. The World Health Organisation (WHO) esti-
mated that the number of persons living with dementia
worldwide (36 million in 2010) will double over the
next 20 years [4]. According to the World Alzheimer
Report from 2013 [5], individuals afflicted with demen-
tia show a high utilization of health services and repre-
sent a significant fraction of the healthcare costs
attributed to the elderly population. In fact, dementia
currently constitutes the main cause of dependence in
the elderly population and is responsible for up to 12%
of the years lived with disability due to a non-
communicable disease [6].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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on average 2 to 8 additional chronic diseases (comorbidities)
[7,8]. They may accelerate progression towards a state of
cognitive and functional impairment that results in the
under-diagnosis and under-treatment of dementia [9]. In
addition, these comorbidities lead to extended hospital
stays and increased healthcare costs and mortality rates
for hospitalized patients [10]. As is true for other clinically
complex circumstances, the presence of comorbidities in
patients with dementia requires us to consider patients
from a global perspective [11], prioritizing certain health
and health outcomes over others, and taking into account
possible conflicts between multiple treatments and recom-
mendations for these patients [12].
The epidemiologic study of comorbidities of an index
diagnosis (dementia, in this case) is complex since, as
Ording et al. recently indicated [13], concepts such as
comorbidity and complications are often difficult to dif-
ferentiate. Furthermore, a cross-sectional vs. life-course
study design can have an important impact on the
direction of the identified associations, as highlighted
in the Neurological Disorders in Central Spain (NEDICES)
Study [14,15]. Still, cross-sectional studies provide a useful
perspective to build future longitudinal and more specific
approaches, especially if techniques that enable the identi-
fication of beyond-chance associations are employed [16].
Improved knowledge of the comorbidities of highly preva-
lent chronic health problems, such as dementia, would facili-
tate the design of preventive strategies aimed at slowing or
avoiding the rapid clinical and functional deterioration which
afflicts patients with this index disease [17]. Moreover, it may
help overcome the potential undertreatment of those disor-
ders that are not designated as the primary condition [18].
This study cross-sectionally describes and analyzes the
comorbidities associated with dementia and reviews the
existing similarities and differences between identified
comorbid diseases using the statistical methods most
frequently applied in current research.
Methods
Study design and participants
A cross-sectional study was performed based on electronic
health record data from primary care. The study popula-
tion comprised individuals 65 years of age and older who,
in the year 2008, consulted their primary care physician at
least once at any of the 19 primary healthcare centers
included in this study. The centers were located in two
regions of Spain: Aragon and Catalonia. The selection
and data-quality criteria for the participating centers
were described elsewhere [19].
The analyzed patient data were age, sex and chronic
diagnoses. To facilitate the use of clinical information,
diagnoses were grouped according to the Expanded
Diagnostic Clusters (EDC) of the ACG® system. To thispurpose, each diagnosis contained in the electronic health
records and originally coded according to the International
Classification of Primary Care (ICPC) was previously trans-
formed into the International Classification of Diseases
(ICD-9-CM). Finally, the ACG® system grouped each ICD-
9-CM code into one of 264 EDCs based on the clinical,
diagnostic and therapeutic similarities of the diseases.
The selection of chronic EDCs was based on a previ-
ous study conducted by Salisbury et al. [20], in which a
chronic disease was defined as “one that normally lasts 6
months or more, including past conditions that require
ongoing disease or risk management. They must be im-
portant conditions with a significant risk of recurrence,
or past conditions that have continuing implications for
patient management”. Dementia was defined using the
EDC NUR11 category “dementia and delirium”, once de-
lirium diagnoses were excluded.
This study was favorably evaluated by the Clinical
Research Ethic Committee of Aragon (CEICA). Written
consent by patients was not needed since the work is
based on the statistical analysis of anonymous data
contained in previously existing databases.
Statistical analysis
Three statistical methods were applied. The first was based
on the analysis of prevalence data, and the remaining two
were based on multivariate analysis techniques (i.e., mul-
tiple logistic regression and exploratory factor analysis).
1) Analysis of prevalence
The prevalence of chronic comorbidities associated
with dementia was calculated for both men and
women. To identify the most prevalent associations,
only combinations of two diseases were considered
(e.g., dementia and a comorbidity), discarding higher
rank-order combinations (e.g., triads and tetrads).
2) Multiple logistic regression models
A multiple logistic regression model was formulated
stratifying by sex and assuming the presence or absence
of dementia as a dependent variable. The remaining
chronic diseases with prevalences equal to or greater
than 1% were considered as covariates for each group
under study. The selection of variables for inclusion in
the model was based on the backward elimination
procedure with an initial inclusion probability of
p < 0.05 and an exclusion probability of p ≥ 0.1.
3) Exploratory factor analysis
Exploratory factor analysis is based on the design of
a mathematical model with the capability of
explaining correlations (covariance) between high
numbers of observed variables and reducing them to
a lower number of latent variables, known as factors
[21]. The objective is the identification of sets of
variables with an underlying common causal factor.
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between groups of variables, allows the same
variable to become part of several factors.
Similar to the logistic regression models, only diseases
with a prevalence of ≥1% were included for each study
group. Factor analysis was based on tetrachoric
correlation matrices [22], and the factors were
extracted using the principal factor method. The
number of factors to be extracted was determined
using scree plots [23] and the clinical evaluation of the
different solutions obtained. The sampling adequacy
was analyzed using the Kaiser-Meyer-Olkin (KMO)
parameter, and the cumulative fraction of total variance
was used as a measure of the model’s goodness of fit.
EDCs with a factor score higher than 0.25 were se-
lected, with the aim of determining the diseases that
composed each pattern.STATA 11.0 software was used for the statistical analyses,
and Excel 2007 was used to produce the corresponding
graphs.
Results
The studied population consisted of 72,815 patients, of
whom 3,971 (5.45%) were diagnosed with dementia. The
frequency of dementia in women was more than double
that in men (Table 1). Patients with dementia were, on
average, four years older than those without the index
disease (80 vs. 76 years). Among the patients with de-
mentia, 12.34% had dementia as the only diagnosis,
69.61% showed at least two comorbidities and 48.05%
showed at least three. The average number of comor-
bidities in the population with dementia (3.69 in men
and 3.68 in women) was significantly higher than in the
population not diagnosed with dementia (2.32 in men
and 2.52 in women).e 1 Study population
Patients ≥65 without demen
Total Men
68,844 (94.55) 28,176 (40.93) 40,
age (SD) 75.53 (7.28) 74.62 (6.85) 76
ber of diseases n (%)
15,052 (21.86) 6,718 (23.84) 8,3
15,934 (23.15) 6,730 (23.89) 9,2
12,795 (18.59) 5,085 (18.05) 7,7
8,500 (12.35) 3,203 (11.37) 5,2
4,604 (6.69) 1,634 (5.80) 2,
3,831 (5.55) 1,320 (4.68) 2,
number of diseases (SD) 2.44 (1.75) 2.32 (1.69) 2
andard deviation.
nts with dementia only.Prevalence of comorbidities
A total of 43 different comorbidities with a prevalence
of ≥1% were identified in the population with dementia
(41 different comorbidities in men and 36 in women).
The 10 diseases with the highest prevalence for both sexes
were hypertension, anxiety and neurosis, degenerative
joint disease, lipid metabolism disorders, lower back
pain, diabetes, anemia, thyroid disease, cataracts and
aphakia, and cardiac arrhythmia (Table 2).
Comorbidities extracted from multiple logistic
regression analysis
Anxiety and neurosis in men (OR, 2.19; 95% CI, 1.84-2.60)
and chronic skin ulcers in women (OR, 2.89; 95% CI,
2.38-3.53) were the diseases with the highest dementia-
association probability. Of the 11 comorbidities found to
be significantly associated with dementia, seven occurred
in both men and women (anxiety and neurosis, Parkinson’s
disease, chronic skin ulcers, anemia, cerebrovascular dis-
ease, cardiac arrhythmia and thyroid disease; Table 3).
Exploratory factor analysis
The factor analysis for the whole population over 64
allowed the identification of three disease patterns in men,
formed by an average of eight diseases. Dementia was
present in only one pattern (Pattern 2) along with congest-
ive heart failure, anemia, Parkinson’s disease, behavioral
problems, chronic skin ulcers, cerebrovascular disease and
osteoporosis (Figure 1).
Four disease patterns were identified in women, formed
by an average of six diseases. As with men, dementia was
present only in a single pattern (Pattern 2) associated with
congestive heart failure, cardiac arrhythmia, anemia, cere-
brovascular disease and chronic skin ulcers (Figure 1).
Therefore, only four diseases were identified (con-
gestive heart failure, anemia, chronic skin ulcers andtia Patients ≥65 with dementia p value
Women Total Men Women
668 (59.07) 3,971 (5.45) 1,185 (29.84) 2,786 (70.16) 0.000
.16 (7.51) 80.22 (7.09) 79.10 (6.94) 80.70 (7.10) 0.000
34 (20.49) 490 (12.34)* 137 (11.56)* 353 (12.67)* 0.000
04 (22.63) 717 (18.06) 218 (18.40) 499 (17.91) 0.000
10 (18.96) 856 (21.56) 260 (21.94) 596 (21.39) 0.000
97 (13.02) 700 (17.63) 222 (18.73) 478 (17.16) 0.000
970 (7.30) 555 (13.98) 151 (12.74) 404 (14.50) 0.000
511 (6.17) 653 (16.44) 197 (16.62) 456 (16.38) 0.000
.52 (1.79) 3.69 (1.95) 3.69 (1.94) 3.68 (1.96) 0.000
Table 2 Prevalence (95% CI) of chronic comorbidities of dementia in ≥65-year-old men and women
Rank Disease Men Disease Women
1 Hypertension 38.6 (35.9 - 41.4) Hypertension 44.9 (43.1 - 46.8)
2 Diabetes 20.3 (18.0 - 22.5) Anxiety, neuroses 23.4 (21.9 - 25.0)
3 Prostatic hypertrophy 19.0 (16.8 - 21.2) Degenerative joint disease 20.5 (19.0 - 22.0)
4 Degenerative joint disease 15.3 (13.2 - 17.3) Disorders of lipid metabolism 18.7 (17.2 - 20.1)
5 Disorders of lipid metabolism 15.3 (13.2 - 17.3) Low back pain 16.6 (15.2 - 18.0)
6 Low back pain 14.1 (12.1 - 16.1) Diabetes 15.8 (14.4 - 17.1)
7 Anxiety, neuroses 13.8 (11.9 - 15.8) Osteoporosis 10.9 (9.8 - 12.1)
8 COPD 11.0 (9.2 - 12.8) Anemia 9.8 (8.7 - 10.9)
9 Cardiac arrhythmia 9.5 (7.9 - 11.2) Thyroid disease 8.4 (7.3 - 9.4)
10 Dermatitis and eczema 9.4 (7.7 - 11.0) Varicose veins of lower extremities 7.4 (6.4 - 8.3)
11 Anemia 9.1 (7.5 - 10.8) Cataracts, aphakia 7.1 (6.1 - 8.0)
12 Cataracts, aphakia 6.8 (5.3 - 8.2) Cardiac arrhythmia 6.9 (5.9 - 7.8)
13 Cerebrovascular disease 6.7 (5.2 - 8.1) Dermatitis and eczema 6.9 (5.9 - 7.8)
14 Ischemic heart disease1 6.6 (5.2 - 8.0) Chronic skin ulcers 4.7 (3.9 - 5.5)
15 Thyroid disease 4.5 (3.3 - 5.7) Cerebrovascular disease 4.6 (3.8 - 5.3)
16 Generalized atherosclerosis 4.2 (3.1 - 5.4) Gastroesophageal reflux 3.9 (3.2 - 4.6)
17 Malignant neoplasms, prostate 4.1 (3.0 - 5.3) Congestive heart failure 3.8 (3.1 - 4.5)
18 Glaucoma 4.0 (2.9 - 5.1) Glaucoma 3.7 (3.0 - 4.4)
19 Gastroesophageal reflux 3.4 (2.3 - 4.4) Ischemic heart disease1 3.3 (2.6 - 4.0)
20 Cervical pain syndromes 3.4 (2.3 - 4.4) Behavior problems 3.1 (2.5 - 3.8)
21 Parkinson's disease 3.0 (2.0 - 3.9) Cervical pain syndromes 3.1 (2.4 - 3.7)
22 Chronic skin ulcers 2.9 (1.9 - 3.8) Asthma 2.6 (2.0 - 3.2)
23 Congestive heart failure 2.8 (1.8 - 3.7) Low-impact malignant neoplasms 2.6 (2.0 - 3.2)
24 Acute myocardial infarction 2.8 (1.8 - 3.7) Obesity 2.6 (2.0 - 3.2)
25 Varicose veins of lower extremities 2.5 (1.6 - 3.4) Cardiovascular disorders, other 2.5 (1.9 - 3.1)
26 Hematologic disorders, other 2.4 (1.5 - 3.2) COPD 2.5 (1.9 - 3.1)
27 Deafness, hearing loss 2.4 (1.5 - 3.2) Hematologic disorders, other 2.2 (1.7 - 2.8)
28 Osteoporosis 2.0 (1.2 - 2.8) Deafness, hearing loss 2.0 (1.5 - 2.6)
29 Low-impact malignant neoplasms 2.0 (1.2 - 2.8) Peripheral neuropathy, neuritis 2.0 (1.5 - 2.5)
30 Obesity 1.9 (1.1 - 2.6) Generalized atherosclerosis 1.8 (1.3 - 2.3)
31 Cardiovascular disorders, other 1.8 (1.0 - 2.5) Depression 1.6 (1.1 - 2.0)
32 Behavior problems 1.7 (1.0 - 2.4) Parkinson's disease 1.5 (1.1 - 2.0)
33 Gout 1.6 (0.9 - 2.3) Diverticular disease of colon 1.4 (1.0 - 1.8)
34 Malignant neoplasms, colorectal 1.5 (0.8 - 2.2) Other endocrine disorders 1.3 (0.9 - 1.7)
35 Retinal disorders2 1.4 (0.7 - 2.0) Thrombophlebitis 1.3 (0.9 - 1.7)
36 Peripheral neuropathy, neuritis 1.2 (0.6 - 1.8) Acute myocardial infarction 1.1 (0.8 - 1.5)
37 Renal calculi 1.2 (0.6 - 1.8)
38 Thrombophlebitis 1.1 (0.5 - 1.7)
39 Diverticular disease of colon 1.0 (0.4 - 1.6)
40 Other endocrine disorders 1.0 (0.4 - 1.6)
41 Substance use 1.0 (0.4 - 1.6)
COPD, chronic obstructive pulmonary disease.
1excluding AMI.
2excluding diabetic retinopathy.
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Table 3 Odds ratios (OR) of dementia-associated chronic comorbidities in ≥65-year-old men and women
Men Women
Disease OR CI 95% Disease OR CI 95%
Anxiety, neuroses 2.19 (1.84 - 2.60) Chronic skin ulcers 2.89 (2.38 - 3.53)
Parkinson's disease 2.13 (1.49 - 3.06) Anxiety, neuroses 1.79 (1.63 - 1.96)
Chronic skin ulcers 2.05 (1.41 - 2.96) Anemia 1.57 (1.37 - 1.79)
Anemia 1.95 (1.58 - 2.41) Cerebrovascular disease 1.57 (1.29 - 1.90)
Retinal disorders 1.72 (1.03 - 2.87) Behavior problems 1.53 (1.22 - 1.92)
Cerebrovascular disease 1.63 (1.28 - 2.07) Congestive heart failure 1.42 (1.15 - 1.75)
Cardiac arrhythmia 1.53 (1.25 - 1.88) Parkinson's disease 1.41 (1.02 - 1.94)
Thyroid disease 1.43 (1.07 - 1.91) Cardiac arrhythmia 1.24 (1.06 - 1.45)
Prostatic hypertrophy 1.29 (1.11 - 1.50) Thyroid disease 1.17 (1.02 - 1.35)
MEN
WOMEN
Figure 1 Disease patterns and factor scores in ≥65-year-old men and women. NOTES: Each spoke of the radar chart represents a disease,
and the lines connecting these spokes represent disease factor scores within each pattern. Only diseases with scores higher than 0.25 are shown.
Underlined diseases belong to the pattern that includes dementia, and represent potential comorbidities of this index disease. KMO: men 0.57;
women: 0.68. % Accumulated variance: men 22.81; women: 24.68.
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http://www.biomedcentral.com/1471-244X/14/84cerebrovascular disease) as forming part of the pattern
that included dementia in both men and women.
Regarding the comparison with results obtained through
logistic regression, both methods agreed on the identifica-
tion of four comorbidities in men (Parkinson’s disease,
chronic skin ulcers, cerebrovascular disease and anemia)
and five comorbidities in women (chronic skin ulcers,
cerebrovascular disease, anemia, congestive heart failure
and cardiac arrhythmia).
Discussion
This study showed that individuals over 64 with dementia
have a significantly higher number of comorbidities than
those not diagnosed with this index disease, thus confirm-
ing previous findings [8,11]. However, this could be due
to the older age of patients with dementia. Among the
multiple chronic comorbidities of dementia, only 12
seem to be significantly associated in the study population
(Parkinson’s disease, congestive heart failure, cerebrovas-
cular disease, anemia, cardiac arrhythmia, chronic skin
ulcers, osteoporosis, thyroid disease, retinal disorders,
prostatic hypertrophy, insomnia and anxiety and neurosis).
The main strength of the study lies in the data source
used. The background is a primary care population served
by a number of healthcare centers where diagnoses are
systematically computer-stored for each patient. Moreover,
the public nature of the healthcare system and high access
of citizens, as well as the one-year observation period
guarantee that selection bias is reduced. Still, our study
is not free from limitations. The most important one
concerns the cross-sectional study design; although this
design allows for the generation of hypotheses regarding
the clinical complexity of dementia, it does not allow
for the determination of causality between the identified
associations. Thus, no distinction can be made among
risk factors, complications and/or simple comorbidities
of dementia. There is evidence that dementia is under-
diagnosed by general practitioners [24]. Regarding the way
dementia was defined, no distinction was made between
the different etiological types of dementia, and there can
be differences between the comorbidities associated with
each one of them [8]. It was neither possible to take into
account the severity of dementia, which is relevant to
the existence of possible comorbidities associated with
functional dependence in these patients. Regarding the
analyzed comorbidities, some non-chronic and/or unspe-
cific conditions (falls, immobilization, etc.) that can also
affect the quality of life of patients could not be included.
The two most frequent comorbidities both for men
and women were hypertension and diabetes, a fact in
disagreement with the results obtained through multi-
variate methods. Indeed, neither logistic regression nor
factor analysis showed significant association between the
aforementioned diseases and dementia, as has been shownpreviously [7,8]. Although hypertension and diabetes are
risk factors for dementia in middle-aged populations, this
association disappears in the elderly population [25].
Furthermore, in the specific case of hypertension, various
longitudinal population-based studies have suggested
that the relationship between hypertension and cognitive
decline is not linear [26,27]. In summary, it is likely that
the high prevalence of hypertension can be explained by
its frequency rather than by the existence of common
underlying pathogenic mechanisms [17]. However, in
the case of diabetes, there is recent knowledge on the
shared nature of type 2 diabetes and neurodegenerative
and arteriosclerotic disorders associated with misfolded
protein deposits [28]. These findings put forward the need
to reinforce the convergence between basic, clinical and
epidemiologic research.
On the other hand, logistic regression and factor analysis
identified different chronic diseases significantly associated
with dementia (Parkinson’s disease, congestive heart fail-
ure, cerebrovascular disease, anemia, cardiac arrhythmia,
chronic skin ulcers, osteoporosis, thyroid disease, retinal
disorders, prostatic hypertrophy, insomnia and anxiety
and neurosis). For most of these comorbidities, a plausible
pathophysiological explanation can be found [11]. Some
could be considered as risk factors (cerebrovascular
disease), others as complications (skin ulcers), and others
just as comorbidities (osteoporosis). Alzheimer’s disease,
preexisting vascular disease and Parkinson’s disease are
among the most frequent etiologies of dementia [29,30].
Functional limitations and the inherent complications and
risks associated with dementia and advanced Parkinson’s
disease (e.g., falls) along with age-related osteoporosis can
lead to fractures, patient immobilization and chronic skin
ulcers, most likely associated with malnourishment and
bedding in these patients [31]. Anemia and cardiac
arrhythmia (mostly in the form of atrial fibrillation) are,
in turn, causes of cerebrovascular disease [32]. Surprisingly,
Zuliani et al. [31] and Sanderson et al. [8] identified a
significant decreased risk of developing anemia and
congestive heart failure among patients with dementia,
but these findings refer to hospitalized patients who
were most likely receiving effective treatments against
both comorbidities, therefore weakening the possible
association between dementia and such comorbidities.
Other studies that used factor analysis have also identi-
fied disease patterns that included dementia. Newcorner
et al. [33] found a pattern they called “frailty in the elderly”
among adult individuals in the United States. In addition
to dementia, this pattern was characterized by the pres-
ence of skin ulcers, ictus, mental health problems and
heart disease, among others. In a study conducted in
Germany by Schäfer et al. [34], a neuropsychiatric pattern
was described in which dementia appeared simultaneously
with heart failure, Parkinson’s disease, depression, urinary
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beit the existence of certain methodological differences,
both studies show similar dementia comorbidity patterns
as the ones obtained here.
Results of this study illustrate the pros and cons of
certain statistical methods for the epidemiologic study of
comorbidities of an index diagnosis. Frequency-based
techniques are determined by the prevalence rates of each
disease in the combinations and therefore have limited
value. For example, given its high prevalence in the
population, hypertension is one of the most frequent
comorbidities of dementia. Thus, it is more informative
to view comorbidities of an index disease from the per-
spective of the non-random association of health problems,
as defined by the term associative comorbidity [16]. Odds
ratios, which are widely used to identify associations
between pairs of diseases [35], do not allow for the study
of the simultaneous presence of diverse comorbidities, nor
do they enable the exploration of possible associations
between diseases that have not been established a priori.
Moreover, such measures of association do not adequately
adjust for chance comorbidity when non-random comor-
bidity exists [35]. Factor analysis allows the visualization
of disease clustering into patterns, offering results of
aetiological interest [19]. In some studies, cluster instead
of factor analysis was applied [36,37], but this technique
does not allow for health problems to simultaneously
belong to more than one cluster. Other alternatives include
the use of comorbidity scores, which incorporate available
diagnostic information into an aggregate index to trace
older patients who are at high risk for hospitalization or
mortality [38,39]. However, these measures preclude esti-
mations of effects of individual or groups of disease [13].
A deep and reliable knowledge about how different
diseases are grouped and associated may orient future
longitudinal studies aimed at unraveling causal associations
[40]. Moreover, the identification of eventual comorbidity
patterns may facilitate diagnosis and effective treatment of
comorbidities among individuals suffering from a given
index disease. Last, knowledge regarding the potential
of such patterns as predictors of intense healthcare use,
adverse health outcomes (e.g., disability, adverse drug
events) and/or increased severity of a given disease could
be incorporated into risk stratification tools [41].
Conclusion
The analysis of the comorbidities associated with an index
disease (e.g., dementia) must not be exclusively based on
prevalence rates, but rather on methodologies that allow
the discovery of non-random associations between diseases.
A deep and reliable knowledge about how different diseases
are grouped and associated around an index disease such
as dementia may orient future longitudinal studies aimed at
unraveling causal associations.Competing interests
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